SCHEMBL3979225

SCHEMBL3979225

CCOC(=O)c1occ(Br)c1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
TSHR P16473 2/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PLK1 P53350 1/20 0.40
KDM4E B2RXH2 2/20 0.39
AHR P35869 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 3/20 0.38
CA9 Q16790 3/20 0.38
CA14 Q9ULX7 3/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4545470 0.80 MAPT (0.41) MAPTTSHRALOX15HSD17B10PLK1
SCHEMBL3977049 0.77 ALDH1A1 (0.47) MAPTTSHRALOX15HSD17B10PLK1
SCHEMBL3977290 0.77 MAPT (0.50) MAPTTSHRPLK1KDM4EAHR
SCHEMBL106736 0.75 TSHR (0.44) MAPTTSHRALOX15HSD17B10PLK1
SCHEMBL4549798 0.74 THRA (0.41) MAPTTSHRALOX15HSD17B10KDM4E
SCHEMBL11273191 0.74 MAPT (0.47) MAPTTSHRALOX15HSD17B10PLK1
SCHEMBL264016 0.71 KDM4E (0.49) MAPTTSHRHSD17B10KDM4EAHR
SCHEMBL7628834 0.70 ALDH1A1 (0.47) MAPTTSHRPLK1KDM4EAHR
SCHEMBL31272272 0.70 CA12 (0.41) MAPTTSHRALOX15HSD17B10PLK1
SCHEMBL3714376 0.70 CYP1A2 (0.40) MAPTTSHRPLK1KDM4EAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 MAPT 4833/4885TSHR 82/4885ALOX15 2249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.